Opexa Therapeutics (OPXA) Reports First Quarter 2013 Financial Results and Provides Corporate Update
5/14/2013 7:38:05 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis (MS), today reported financial results for the quarter ended March 31, 2013 and provided an overview of recent corporate developments.
Help employers find you! Check out all the jobs and post your resume.
comments powered by